Display options
Cite
Shiratori T, Sato A, Fukuzawa M, et al. Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage. Case Rep Crit Care. 2015;2015:967560doi: 10.1155/2015/967560.
Shiratori, T., Sato, A., Fukuzawa, M., Kondo, N., & Tanno, S. (2015). Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage. Case reports in critical care, 2015967560. https://doi.org/10.1155/2015/967560
Shiratori, Tohru, et al. "Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage." Case reports in critical care vol. 2015 (2015): 967560. doi: https://doi.org/10.1155/2015/967560
Shiratori T, Sato A, Fukuzawa M, Kondo N, Tanno S. Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage. Case Rep Crit Care. 2015;2015:967560. doi: 10.1155/2015/967560. Epub 2015 Jun 11. PMID: 26171255; PMCID: PMC4480245.
Copy Download .nbib Format: NLM
Share it on

Case Rep Crit Care. 2015;2015:967560. doi: 10.1155/2015/967560. Epub 2015 Jun 11.

Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage.

Case reports in critical care

Tohru Shiratori, Atsushi Sato, Masao Fukuzawa, Naoko Kondo, Shogo Tanno

Affiliations

  1. Division of Intensive Care Unit, Ina Central Hospital, 1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan.
  2. Department of Neurosurgery, Ina Central Hospital, 1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan.
  3. Department of Dermatology, Ina Central Hospital, 1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan.
  4. Department of Anesthesiology, Ina Central Hospital, 1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan.
  5. Department of Emergency Medicine, Ina Central Hospital, 1313-1 Koshiroukubo, Ina, Nagano 396-8555, Japan.

PMID: 26171255 PMCID: PMC4480245 DOI: 10.1155/2015/967560

Abstract

Dextran is a colloid effective for volume expansion; however, a possible side effect of its use is anaphylaxis. Dextran-induced anaphylactoid reaction (DIAR) is a rare but severe complication, with a small dose of dextran solution sufficient to induce anaphylaxis. An 86-year-old female who underwent clipping for a ruptured cerebral aneurysm was admitted to the intensive care unit. Prophylactic hypertension-hypervolemia-hemodilution therapy was induced for cerebral vasospasm following a subarachnoid hemorrhage. The patient went into severe shock after administration of dextran for volume expansion, and dextran administration was immediately discontinued. The volume administered at that time was only 0.8 mL at the most. After fluid resuscitation with a crystalloid solution, circulatory status began to recover. However, cerebral vasospasm occurred and the patient's neurological condition deteriorated. Five weeks after the shock, she was diagnosed with hypersensitivity to dextran by a skin test. When severe hypotension occurs after dextran administration, appropriate treatments for shock should be performed immediately with discontinuation of dextran solution. Although colloid administration is recommended in some guidelines and researches, it is necessary to consider concerning the indication for volume expansion as well as the risk of colloid administration.

References

  1. Interv Neurol. 2013 Oct;2(1):30-51 - PubMed
  2. J Cereb Blood Flow Metab. 2010 Apr;30(4):689-702 - PubMed
  3. J Vasc Surg. 2006 May;43(5):1004-9 - PubMed
  4. Anesth Analg. 2003 Mar;96(3):859-61, table of contents - PubMed
  5. Anesth Analg. 1998 May;86(5):1123-6 - PubMed
  6. Arch Biochem Biophys. 1958 Dec;78(2):306-18 - PubMed
  7. Asia Pac Allergy. 2013 Oct;3(4):266-80 - PubMed
  8. Neurosurgery. 2001 Sep;49(3):593-605; discussion 605-6 - PubMed
  9. Neurosurgery. 2010 Jan;66(1):35-41; discussion 41 - PubMed
  10. Allergy. 2000 Nov;55(11):1098-9 - PubMed
  11. Anesthesiology. 1987 Oct;67(4):567-9 - PubMed
  12. Crit Care Med. 2013 Jan;41(1):195-204 - PubMed
  13. Anaesthesia. 1988 Sep;43(9):729-32 - PubMed
  14. J Neuroinflammation. 2011 Nov 24;8:164 - PubMed
  15. Anaesth Intensive Care. 1987 May;15(2):163-7 - PubMed
  16. J Vasc Surg. 2006 May;43(5):1070-2 - PubMed
  17. Anesthesiology. 2014 Aug;121(2):272-9 - PubMed
  18. Minerva Anestesiol. 2014 Aug;80(8):963-9 - PubMed
  19. Anaesthesia. 1991 Dec;46(12):1033-5 - PubMed
  20. Neurocrit Care. 2011 Sep;15(2):329-35 - PubMed
  21. Allergy. 2013 Jun;68(6):702-12 - PubMed
  22. Shock. 2012 Oct;38(4):429-35 - PubMed
  23. Infusionsther Transfusionsmed. 1993 Oct;20(5):206-10 - PubMed
  24. Aust Fam Physician. 2012 Jun;41(6):366-70 - PubMed
  25. Korean J Anesthesiol. 2012 Sep;63(3):260-2 - PubMed
  26. Anesth Analg. 2003 May;96(5):1453-9, table of contents - PubMed
  27. Int Arch Allergy Appl Immunol. 1982;68(2):122-6 - PubMed
  28. Acta Chir Scand. 1983;149(3):253-62 - PubMed
  29. Anaesthesia. 1999 Jul;54(7):678-82 - PubMed
  30. World Allergy Organ J. 2014 May 30;7(1):9 - PubMed
  31. Anesth Analg. 2003 Nov;97(5):1381-95 - PubMed
  32. Eur Surg Res. 1992;24(3):138-42 - PubMed
  33. Am J Physiol. 1985 Aug;249(2 Pt 2):H430-7 - PubMed
  34. Int Endod J. 2014 Apr;47(4):309-13 - PubMed
  35. Case Rep Crit Care. 2014;2014:630970 - PubMed
  36. Drug Saf. 1992 Jan-Feb;7(1):71-3 - PubMed
  37. Allergy. 2014 Apr;69(4):420-37 - PubMed

Publication Types